Punch & Associates Investment Management’s Merck MRK Stock Holding History

Punch & Associates Investment Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$218K	–	213
2023 Q4	$218K	Hold	2,000	–	–	0.01%	202
2023 Q3	$206K	Hold	2,000	–	–	0.01%	200
2023 Q2	$231K	Hold	2,000	–	–	0.01%	194
2023 Q1	$213K	Hold	2,000	–	–	0.01%	196
2022 Q4	$222K	Buy	+2,000	New	+$204K	0.01%	200

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Punch & Associates Investment Management's MRK Position: Q1 2024 in Review

Punch & Associates Investment Management sold out of Merck (MRK) in Q1 2024, closing a stake of 2,000 shares — an estimated $218K sold.

Punch & Associates Investment Management first reported a position in MRK in Q4 2022 and held it in 5 quarters. The position peaked at $231K in Q2 2023. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

Punch & Associates Investment Management reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
Punch & Associates Investment Management sold 2,000 Merck shares in Q1 2024, an estimated $218K.
Punch & Associates Investment Management first reported a position in Merck in Q4 2022 and held it in 5 quarters.
Punch & Associates Investment Management's Merck position peaked at $231K in Q2 2023.
3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Punch & Associates Investment Management's 13F filing for Q1 2024, filed 15 May 2024.